Skip to content

Short Term Effect of Cervical Mobilization vs Manipulation on Blood Pressure in Hypertensive Subjects

Short Term Effect of Cervical Mobilization vs Manipulation on Blood Pressure in Hypertensive Subjects( Randomized Control Trial)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05420298
Enrollment
40
Registered
2022-06-15
Start date
2022-06-01
Completion date
2023-07-04
Last updated
2023-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Brief summary

Spinal pain or misalignment is a very common disorder affecting a significant number of populations resulting in substantial disability and economic burden. Various manual therapeutic techniques such as spinal manipulations and mobilizations can be used to treat and manage pain and movement dysfunctions such as spinal malalignments and associated complications. These manual therapeutic techniques can affect the cardiovascular parameters . \-

Detailed description

Group A group (n=20). All participants will receive only single session of neck mobilization. Grade IV unilateral posteroanterior pressure and sustained extension to be applied restricted joints and muscle energy technique. \- Group B (n=20) will receive single session of neck manipulation with high-velocity, low-amplitude thrust over restricted joints (one at a time) with the goal of restoring normal range of motion in the joint.

Interventions

All participants will receive only single session of cervical mobilization

All participants will receive only single session of cervical manipulation

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
27 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* SBP ranging from 135 to 159 mm Hg or DBP ranging from 85 to 99 mm Hg over 3 qualifying BP screening visits * The age of participants will range from 27 to 60 years old. * Body mass index of participants will range between \< 39 kg/m².

Exclusion criteria

* cardiovascular diseases or surgery, including second- or third-degree heart block, angina pectoris, defibrillator, valvular disease, recent myocardial infarction, cardiac surgery in the past 12 months. * history of stroke. * body mass index (BMI) greater than 39 kg/m2. * pregnancy.

Design outcomes

Primary

MeasureTime frameDescription
systolic blood pressure measurementit will be measured immediately before and after single session treatmentsystolic pressure - the pressure when your heart pushes blood out and is measured by Mercury sphygmomanometer and stethoscope

Secondary

MeasureTime frameDescription
diastolic blood pressureit will be measured immediately before and after single session treatmentthe pressure when your heart rests between beats is measured by Mercury sphygmomanometer and stethoscope
oxygen saturationit will be measured immediately before and after single session treatmentOxygen saturation is a vital parameter to define blood oxygen content and oxygen delivery and is measured by pulse oximetry
perfusion indexit will be measured immediately before and after single session treatmentPerfusion index is an indication of the pulse strength at the sensor site. The PI's values range from 0.02% for very weak pulse to 20% for extremely strong pulse.Perfusion index is normally monitored with pulse oximeters
pain assessmentit will be measured immediately before and after single session treatmentThe visual analog scale (VAS) is a tool widely used to measure pain

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026